Strengthening the healthcare supply chain in a post-pandemic world

Thursday, July 14th, 2022 | 1:00 PM - 2:00 PM CT 

The COVID-19 pandemic put a stark spotlight on the healthcare supply chain's vulnerabilities. Global disruptions hindered America's access to essential medicines and healthcare supplies, threatening care quality and staff safety. The never-before-seen pressures on providers and manufacturers resulted in incredible examples of adaptability and resilience, but challenges remain.

Healthcare leaders must respond to these challenges, while also planning for a future that may be defined by similar uncertainties. Join this session to dive deeper into the current state of the healthcare supply chain, including efforts to boost U.S. manufacturing and how healthcare organizations can create more agile supply chains.

Participants will gain a better understanding of:

  • How the COVID-19 pandemic accelerated certain trends in healthcare
  • Policy discussions and legislative efforts to bolster U.S. healthcare manufacturing and supply chains
  • How providers are adapting care teams and using technology to meet patients' and employees' needs
  • How the U.S. government and manufacturers are planning to mitigate future shortages and strengthen the domestic supply chain


Meacham_Scott_Head Shot 2_02.25.2019

Scott Meacham

President, Pharmaceuticals, Fresenius Kabi USA


Captain Valerie Jensen

USPHS, (Ret.), Associate Director, CDER Drug Shortage Staff, FDA

J Kimball photo AAM 2021

Jonathan Kimball

Vice President, Trade, International Affairs, and Strategic Initiatives, Association for Accessible Medicines

Loressa Cole head shot (1)

Loressa Cole, DNP, MBA, RN, NEA-BC, FAAN

CEO, American Nurses Association Enterprise